Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06713473 · ClinicalTrials.gov registry record · NA
Reducing Self-Dehumanization to Examine Oxytocin and Suicide Risk
A NA study, sponsored by Florida State University.
- Not yet
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT06713473 is a NA study that has not yet begun recruiting, run by Florida State University. The registered enrollment target is 50 participants.
The verdict
NCT06713473, a NA study, has not yet begun recruiting, sponsored by Florida State University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The goal of this experiment is to further determine if self-dehumanization is a novel risk factor for suicide. This study will reduce self-dehumanization using a novel re-humanization condition and compare this group to a control group to analyze the pathway between higher perceptions of self-dehumanization, suicidal ideation, and changes in oxytocin concentrations. It is hypothesized that participants randomly assigned to the re-humanized condition will exhibit decreases in suicidal ideation and increases in oxytocin concentrations as compared to the control condition, which will not display significant changes. Further, we will explore if the magnitude of the oxytocin response will partially mediate the change in suicidal ideation.
Interventions
- OTHER Blood Draw
- OTHER Control Intervention
- DIAGNOSTIC_TEST Clinical Interview
- OTHER Rehumanized Intervention
- OTHER Self-Report Measures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-08 |
| Est. Completion | 2028-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06713473
The ClinicalTrials.gov registry entry for NCT06713473 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Blood Draw is the first listed.
NCT06713473 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06713473 about?
NCT06713473 is a clinical study titled "Reducing Self-Dehumanization to Examine Oxytocin and Suicide Risk". The goal of this experiment is to further determine if self-dehumanization is a novel risk factor for suicide. This study will reduce self-dehumanization using a novel re-humanization condition and compare this group to a control group to analyze the pathway between higher perceptions of self-dehuma...
What is the current status of trial NCT06713473?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-08. Estimated completion is 2028-08.
What interventions are being tested in trial NCT06713473?
The interventions under investigation include: Blood Draw (OTHER), Control Intervention (OTHER), Clinical Interview (DIAGNOSTIC_TEST), Rehumanized Intervention (OTHER), Self-Report Measures (OTHER).
Who is sponsoring clinical trial NCT06713473?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.